Pathology Analysis & Statistics, January 2015 (p20)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

All regions

571-600 of about 4 800 reports

Purchase Reports From Reputable Market Research Publishers

Merrion Pharmaceuticals Plc (Symbol:3MP) SWOT Analysis, Strategy, Revenues and Profits

Merrion Pharmaceuticals Plc (Symbol:3MP) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
Microbio Co., Ltd. (Symbol:4128) SWOT Analysis, Strategy, Revenues and Profits

Microbio Co., Ltd. (Symbol:4128) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Taiwan
Medivir AB (MVIR B) - Financial and Strategic SWOT Analysis Review

Medivir AB (MVIR B) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Medivir AB (Medivir) is a bio-pharmaceutical company. The company concentrates on the research and development of drugs for the treatment of infectious diseases. It provides drugs for the disorders ...

  • Industries : Pathology
  • Countries : Sweden
Sinovac Biotech Ltd. (Symbol:SVA) SWOT Analysis, Strategy, Revenues and Profits

Sinovac Biotech Ltd. (Symbol:SVA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : China
Somnomed Limited (Symbol:SOMDA) SWOT Analysis, Strategy, Revenues and Profits

Somnomed Limited (Symbol:SOMDA) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Australia, United States
Sosei Co. Ltd. (Symbol:4565) SWOT Analysis, Strategy, Revenues and Profits

Sosei Co. Ltd. (Symbol:4565) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
Strides Arcolab Limited (STAR) - Financial and Strategic SWOT Analysis Review

Strides Arcolab Limited (STAR) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Strides Arcolab Limited (Strides Arcolab) is a pharmaceutical company. The company specializes in manufacturing IP-led niche generics and bio-pharmaceuticals. Strides Arcolab serves areas such ...

  • Industries : Pathology
  • Countries : United States, World, Australia, South Africa
Sunshine Biopharma, Inc. (Symbol:SBFM) SWOT Analysis, Strategy, Revenues and Profits

Sunshine Biopharma, Inc. (Symbol:SBFM) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : Canada
TapImmune Inc. (Symbol:TPIV) SWOT Analysis, Strategy, Revenues and Profits

TapImmune Inc. (Symbol:TPIV) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Tengion, Inc. (Symbol:TNGN) SWOT Analysis, Strategy, Revenues and Profits

Tengion, Inc. (Symbol:TNGN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
The GEO Group, Inc. (Symbol:GEO) SWOT Analysis, Strategy, Revenues and Profits

The GEO Group, Inc. (Symbol:GEO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States, Australia, South Africa
Tikcro Technologies, Ltd. (Symbol:TIKRF) SWOT Analysis, Strategy, Revenues and Profits

Tikcro Technologies, Ltd. (Symbol:TIKRF) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
Pacific Edge Limited (Symbol:PEB) SWOT Analysis, Strategy, Revenues and Profits

Pacific Edge Limited (Symbol:PEB) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : New Zealand, Australia
Zealand Pharma A/S (Symbol:ZEAL) SWOT Analysis, Strategy, Revenues and Profits

Zealand Pharma A/S (Symbol:ZEAL) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
AtheroNova Inc. (Symbol:AHRO) SWOT Analysis, Strategy, Revenues and Profits

AtheroNova Inc. (Symbol:AHRO) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
  • Countries : United States
Oneness Biotech Co., Ltd. (Symbol:4743) SWOT Analysis, Strategy, Revenues and Profits

Oneness Biotech Co., Ltd. (Symbol:4743) SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • January 2015
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

  • Industries : Pathology
Endocyte, Inc. (ECYT) - Financial and Strategic SWOT Analysis Review

Endocyte, Inc. (ECYT) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Endocyte, Inc. (Endocyte) is a biopharmaceutical company. The company develops and markets therapies for the treatment of cancer and other inflammatory diseases. Its pipeline products include Vynfinit ...

  • Industries : Pathology
  • Countries : United States
Galena Biopharma, Inc. (GALE) - Financial and Strategic SWOT Analysis Review

Galena Biopharma, Inc. (GALE) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Galena Biopharma, Inc. (Galena) is a biotechnology company. The company discovers, develops and commercializes therapies for the treatment of unmet medical needs, and advance care. Its products ...

  • Industries : Pathology
  • Countries : United States
RaQualia Pharma Inc. (4579) - Financial and Strategic SWOT Analysis Review

RaQualia Pharma Inc. (4579) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary RaQualia Pharma Inc. (RaQualia) is a pharmaceutical company. The company discovers, develops and markets clinical and preclinical candidates for human patients worldwide. Its products include anidulafungin, ...

  • Industries : Pathology
China Medical System Holdings Limited (867) - Financial and Strategic SWOT Analysis Review

China Medical System Holdings Limited (867) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary China Medical System Holdings Limited (CMS) is a pharmaceutical service provider. The company provides marketing promotion and sale of prescription drugs to all therapeutic departments in hospitals. ...

  • Industries : Pathology
  • Countries : China
Gufic BioSciences Limited (GUFICBIO) - Financial and Strategic SWOT Analysis Review

Gufic BioSciences Limited (GUFICBIO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Gufic BioSciences Limited (Gufic) is a generic pharmaceutical company. It carries out development, manufacturing and marketing of pharmaceutical, generics, herbal, API's and healthcare products. ...

  • Industries : Pathology
Enzymatica AB (ENZY) - Financial and Strategic SWOT Analysis Review

Enzymatica AB (ENZY) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Enzymatica AB (Enzymatica) is a biotechnology company. It carries out the research, development and registration of medical products, based on a patented enzyme technology. The company focuses ...

  • Industries : Pathology
  • Countries : Sweden
Pharmaxis Limited (PXS) - Financial and Strategic SWOT Analysis Review

Pharmaxis Limited (PXS) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Pharmaxis Ltd. (Pharmaxis) is a pharmaceutical company. The company develops products for diagnosis and treatment of chronic respiratory and immune disorders. It offers products such as include ...

  • Industries : Pathology
  • Countries : Australia, South Korea
Acasti Pharma Inc. (APO) - Financial and Strategic SWOT Analysis Review

Acasti Pharma Inc. (APO) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Acasti Pharma Inc. (Acasti) is a biopharmaceutical company. The company researches, develops and commercializes active pharmaceutical ingredients for the management of cardiometabolic disorders. ...

  • Industries : Pathology
  • Countries : Canada
ChemoCentryx, Inc. (CCXI) - Financial and Strategic SWOT Analysis Review

ChemoCentryx, Inc. (CCXI) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary ChemoCentryx, Inc. (ChemoCentryx) is a biopharmaceutical company. The company discovers, and develops orally-administered therapeutics to treat autoimmune diseases, inflammatory disorders and cancer. ...

  • Industries : Pathology
  • Countries : United States
Intec Pharma ltd. (INTP) - Financial and Strategic SWOT Analysis Review

Intec Pharma ltd. (INTP) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Intec Pharma ltd. (Intec Pharma) is a biopharmaceutical company. It develops and markets improved drug formulations of existing drugs. The company's pipeline product portfolio comprises drug indications ...

  • Industries : Pathology
GlaxoSmithKline Consumer Nigeria PLC (GLAXOSMITH) - Financial and Strategic SWOT Analysis Review

GlaxoSmithKline Consumer Nigeria PLC (GLAXOSMITH) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary GlaxoSmithKline Consumer Nigeria PLC (GlaxoSmithKline) is a pharmaceutical and healthcare company. The company develops and markets consumer healthcare and pharmaceutical products. Its products ...

  • Industries : Pathology
  • Countries : Nigeria
D-Pharm Ltd. (DPRM) - Financial and Strategic SWOT Analysis Review

D-Pharm Ltd. (DPRM) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary D-Pharm Ltd. (D-Pharm) is a clinical stage biopharmaceutical company. It focuses on the discovery and development of drugs for the treatment of degenerative and age-related disorders especially ...

  • Industries : Pathology
  • Countries : Israel
PharmaEngine, Inc. (4162) - Financial and Strategic SWOT Analysis Review

PharmaEngine, Inc. (4162) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary PharmaEngine, Inc. (PharmaEngine) is a biopharmaceutical company. The company develops and commercializes drugs for the treatment of cancer and Asian prevalent diseases. Its major product pipeline ...

  • Industries : Pathology
  • Countries : Taiwan
Brainsway Ltd. (BRIN) - Financial and Strategic SWOT Analysis Review

Brainsway Ltd. (BRIN) - Financial and Strategic SWOT Analysis Review

  • $ 300
  • Company report
  • January 2015
  • by Global Data

Summary Brainsway Ltd. (Brainsway) is a manufacturer of medical devices. The company develops and markets transcranial magnetic stimulation systems and noninvasive medical device for treatment of a wide ...

  • Industries : Pathology
  • Countries : Israel
About 34 000 reports

Download Unlimited Documents from Trusted Public Sources

Pathology Description in the US

  • March 2015
    9 pages
  • Pathology  

    Tuberculosis  

  • United States  

View report >

About 200 Companies

Read our Company Profiles

GlaxoSmithKline P.L.C.

United States

Novartis Inc.

Switzerland

GlaxoSmithKline PLC

United Kingdom

AstraZeneca PLC

United Kingdom

Pfizer Inc.

United States

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.